timolol has been researched along with travoprost in 105 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 51 (48.57) | 29.6817 |
| 2010's | 50 (47.62) | 24.3611 |
| 2020's | 4 (3.81) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Andrew, R; Bergamini, MV; Davis, AA; Dickerson, J; Landry, T; Mallick, S; Netland, PA; Robertson, SM; Silver, L; Sullivan, EK; Weiner, A | 1 |
| Cunha-Vaz, J; Goldberg, I; Jakobsen, JE; Nordmann, JP; Sullivan, EK; Trost, E | 1 |
| Davis, AA; Landry, T; Orengo-Nania, S; Silver, LH; Von Tress, M; Weiner, A | 1 |
| Davis, AA; Fellman, RL; Ratliff, M; Silver, LH; Sullivan, EK; Turner, FD; Weiner, AL; Whitson, JT | 1 |
| Camras, CB | 1 |
| Whitson, JT | 1 |
| Goldberg, I | 1 |
| Andrew, R; Barnes, G; Bergamini, MV; Bishop, JE; Davis, AA; Dean, TR; DeFaller, J; DeSantis, L; Hellberg, MR; Klimko, PG; Kothe, A; Kyba, EP; Landry, T; McLaughlin, MA; Robertson, S; Sallee, VL; Selliah, RD; Sharif, NA; Silver, L; Sullivan, EK; Weiner, AL; Zinke, PW | 1 |
| Camras, CB; Eisenberg, DL; Toris, CB | 1 |
| Covert, DW; Halpern, MT; Robin, AL | 1 |
| Ardelean, C; Nenciu, A; Stefan, C | 1 |
| Castillo, A; Fernandez-Vidal, A; Garcia-Feijoo, J; Garcia-Sanchez, J; Martinez-de-la-Casa, JM; Mendez-Hernandez, C | 1 |
| Barnebey, HS; Bergamini, MV; Flowers, BE; Landry, TA; Mallick, S; Orengo-Nania, S; Samples, J | 1 |
| Katz, LJ | 1 |
| Bergamini, MV; Henry, JC; Katz, GJ; Landry, TA; Lewis, RA; Mallick, S; Robertson, SM; Schuman, JS; Sullivan, EK; Wells, DT | 1 |
| Bacharach, J; Bergamini, MV; Craven, ER; Hughes, BA; Kaback, MB; Landry, TA; Mallick, S | 1 |
| Aagren, M; Buchholz, P; Holmstrom, S; Walt, J; Wickstrøm, J | 1 |
| Antohi, I; Chiseliţă, D; Danielescu, C; Medvichi, R | 1 |
| Charles, SJ; Vishwanath, MR | 1 |
| Cunliffe, IA; Franks, WA; Renard, JP; Rojanapongpun, P | 1 |
| Avila, MP; Magacho, L; Queiroz, CF; Reis, R; Santos, LC | 1 |
| Cerovski, B; Jukić, T; Popović Suić, S; Vukojević, N | 1 |
| Hoy, SM; Keam, SJ; Keating, GM | 1 |
| Covert, DW; Halpern, MT; Robin, AL; Schmier, JK | 1 |
| Batista, WD; da Silva, LJ; Figueiredo, CR; Franklin, LM; Netto, JA; Suzuki, ER | 1 |
| Chen, XM; Li, N; Wei, ML; Yao, X; Zhou, Y | 1 |
| Awadallah, NS; Kahook, MY; Noecker, RJ | 1 |
| Berdeaux, G; Lafuma, A | 1 |
| Küsbeci, T; Oztürk, F; Yavas, GF | 1 |
| Konstas, AG; Kruft, B; Nelson, LA; Stewart, WC | 1 |
| Buchholz, P; Ferreras, A; Friis, MM; Gouws, P; Hommer, A; Steeds, C; Thygesen, J; Wickstrøm, J | 1 |
| Herceg, M; Noecker, R | 1 |
| Holló, G; Kóthy, P | 1 |
| Arend, KO; Raber, T | 1 |
| Melo, LA; Piassi, MV; Prata, TS | 1 |
| Skorkovská, K | 1 |
| Maguire, K; Ng, CH; Schweitzer, I | 1 |
| Martínez, A; Slof, J | 1 |
| Berdeaux, G; Denis, P; Jeanbat, V; Lafuma, A; Laurendeau, C | 1 |
| Haidich, AB; Konstas, AG; Mikropoulos, D; Ntampos, KS; Stewart, WC | 1 |
| Berdeaux, G; De Natale, R; Lafuma, A | 1 |
| Călugăru, D; Călugăru, M | 3 |
| Konstas, AG; Nasr, MB; Nelson, LA; Stewart, JA; Stewart, WC; Tsironi, S; Vakalis, AN | 1 |
| Delgado-Ortega, L; Díaz-Cerezo, S; Pinazo-Durán, MD; Soto-Alvarez, J; Vinuesa-Silva, I; Vinuesa-Silva, JM | 1 |
| Cai, JP; Cheng, JW; Wei, RL | 1 |
| Jamshidian-Tehrani, M; Mehdizadeh, M; Nowroozzadeh, MH | 1 |
| Laxmana Rao, HB; Sekhar, GC | 1 |
| Soto, J | 1 |
| Bellini, R; Bracchino, M; Bucarelli, M; Caravati, C; Celesia, L; Cerqueti, P; Clemente, A; Franchin, S; Pasinetti, GM; Rossi, GC; Tinelli, C | 1 |
| Bojić, L; Capkun, V; Ivanisević, M; Kovacić, Z; Rogosić, V; Stanić, R | 1 |
| Bianchi, PE; Milano, G; Pasinetti, GM; Rossi, GC; Scudeller, L; Tinelli, C | 1 |
| Dimopoulos, AT; Embeslidis, TA; Haidich, AB; Konstas, AG; Mikropoulos, DG; Papanastasiou, A; Stewart, WC | 1 |
| Boehm, A; Centofanti, M; Gandolfi, S; Haustein, M; Hommer, A; Manni, G; Oddone, F; Rossetti, L; Sangermani, C; Sportelli, V; Tanga, L | 1 |
| Bojić, L; Dosen, VM; Ekert, M; Laus, KN; Mandić, Z; Suić, SP | 1 |
| Della Paolera, M; Giampani, J; Lottenberg, CL; Mendonça, M; Paranhos, A; Russ, H; Silva, MJ; Torres, RJ | 1 |
| Crowston, JG; Goldberg, I; Jasek, MC; Stewart, JA; Stewart, WC | 1 |
| Biuk, D; Bojic, L; Dobutovic, D; Kovacic, Z; Mandic, Z; Maricic-Došen, V; Novak-Lauš, K; Pavan, J; Pelcic, G; Popovic-Suic, S | 1 |
| Denis, P | 1 |
| Baudouin, C; Brignole-Baudouin, F; Liang, H; Nakib, Z; Riancho, L | 1 |
| Baudouin, C; Brignole-Baudouin, F; Liang, H; Pauly, A; Riancho, L | 1 |
| Pfeiffer, N | 1 |
| Ito, Y; Murao, T; Nagai, N; Oe, K; Okamoto, N; Shimomura, Y | 1 |
| Cai, SP; Liu, G; Liu, X; Pang, IH; Wang, H; Yan, N; Yu, W; Zeng, T | 1 |
| Liu, JH; Realini, T; Weinreb, RN | 1 |
| Bae, K; Iwamoto, Y; Kitazawa, Y; Kotake, S; Sasaki, N; Smith, P | 1 |
| Pachimkul, P; Thoophom, P; Yuttitham, K | 1 |
| Ammar, DA; Kahook, MY | 1 |
| Liehneova, I; Negrete, FJ; Scherzer, ML; Schnober, D | 1 |
| Babić, N; Camara, C; Cieślińska, I; Ferkova, S; Holló, G; Januleviciene, I; Kaluzny, BJ; Kóthy, P; Kozobolis, V; Kristoffersen, MS; Krzyzanowska-Berkowska, P; Mikropoulos, DG; Misiuk-Hojlo, M; Nelson, LA; Quaranta, L; Russo, A; Stewart, JA; Stewart, WC; Teus, MA; Thelen, U | 1 |
| Barisić, F; Biuk, D; Bojić, L; Clementi, D; Dobutović, D; Dogan, KK; Dosen, VM; Ekert, M; Geser, MZ; Iveković, R; Jurić-Miletić, A; Kovacević, S; Kovacić, Z; Krolo, I; Mandić, Z; Novak-Laus, K; Pavan, J; Pelcić, G; Popović-Suić, S; Susić, N; Tomić, M | 1 |
| Escalada, A; García Sánchez, J; García-Feijoó, J; Martínez-de-la-Casa, JM; Sáenz-Francés, F; Sánchez-Pulgarín, M | 1 |
| Cho, HK; Moon, JI; Park, MH | 2 |
| Konstas, AG; Quaranta, L; Realini, T | 1 |
| Cojocaru, I; Pop, A; Stefan, C | 1 |
| Kashiwagi, K | 1 |
| Georgiev, GA; Ivanova, S; Krastev, R; Lalchev, Z; Yokoi, N | 1 |
| Beckers, HJ; Brink, HM; Busch, MJ; Colen, TP; Schouten, JS; Webers, CA | 1 |
| Balbaba, M; Çelebi, S; Ulaş, F | 1 |
| Giannopoulos, T; Haidich, AB; Holló, G; Konidaris, V; Konstas, AG; Mikropoulos, DG; Paschalinou, E; Samples, JR; Voudouragkaki, IC | 1 |
| Enoki, T; Hirota, N; Kanda, T; Kojima, T; Mizukawa, A; Sato, H; Shoji, T; Takeuchi, M | 1 |
| Nixon, DR | 1 |
| Barros, Jde N; Faria, NV; Gomes, JÁ; Mello, PA; Montiani-Ferreira, F; Nogueira-Filho, PA; Russ, HH | 1 |
| Coban, DT; Erol, MK; Yucel, O | 1 |
| Hirota, A; Ichioka, I; Kanamoto, T; Kimura, W; Kiuchi, Y; Miyoshi, T; Mukai, S; Nagaya, M; Onishi, T; Osada, K; Suchiro, T; Yoshi, H | 1 |
| Boboridis, KG; Dragoumis, ND; Giannopoulos, T; Haidich, AB; Kahook, MY; Konstas, AG; Makridis, AK; Paschalinou, E; Voudouragkaki, IC | 1 |
| Bautista, D; Chew, PT; Khoo, AL; Lim, BP; Lin, L; Sng, CC; Teng, M; Wong, HT; Wu, TS; Yip, LW; Zhao, YJ | 1 |
| Kumar, MS; Mishra, D; Sinha, BP | 1 |
| Cheng, JW; Lou, H; Wang, H; Wei, RL; Zong, Y | 1 |
| Kanda, T; Mine, I; Sakurai, Y; Shibata, M; Taguchi, M; Takeuchi, M | 1 |
| Barnebey, HS; Robin, AL | 1 |
| Ates, H; Degirmenci, C; Guven Yilmaz, S; Karakoyun, YE; Yusifov, E | 1 |
| Aljasim, LA; Bradfield, Y; Dixon, ER; Feldman, R; Gustafson, N; Landry, T; Salem, C; Venkataraman, S | 1 |
| Agnifili, L; Brescia, L; Fasanella, V; Mastropasqua, L; Mastropasqua, R; Oddone, F; Scatena, B | 1 |
| Carleton, B; Etminan, M; Mikelberg, FS; Wendel, C; Zakrzewski, H | 1 |
| Hayashi, K; Manabe, SI; Sato, T; Yoshida, M | 1 |
| Brown, GC; Brown, MM | 1 |
| Fang, Y; Gan, D; Jiang, R; Ku, H; Sun, X | 1 |
| Huang, S; Xing, Y; Zhang, K; Zhu, L | 1 |
| Barbeau, M; Beauchemin, C; Cui, AX; Harasymowycz, P; Jobin-Gervais, K; Lachaine, J; Mathurin, K; Royer, C | 1 |
| Fassari, C; Holló, G; Kirwan, J; Lopez-Lopez, F; Oddone, F; Zimina, M | 1 |
| Gugleta, K; Hasler, PW; Saruhan, Y | 1 |
21 review(s) available for timolol and travoprost
| Article | Year |
|---|---|
Travoprost--a new prostaglandin analogue for the treatment of glaucoma.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Clinical Trials as Topic; Cloprostenol; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glaucoma; Humans; Intraocular Pressure; Ocular Hypertension; Racial Groups; Receptors, Prostaglandin; Timolol; Travoprost | 2002 |
Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Lipids; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Timolol; Travoprost | 2002 |
Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucoma.
Topics: Adrenergic beta-Antagonists; Adult; Amides; Bimatoprost; Clinical Trials as Topic; Cloprostenol; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Lipids; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Timolol; Travoprost; Treatment Outcome | 2005 |
Travoprost/timolol.
Topics: Cloprostenol; Drug Combinations; Glaucoma; Humans; Patient Compliance; Timolol; Travoprost | 2006 |
Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.
Topics: Aged; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Dinoprost; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Lipids; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Timolol; Travoprost | 2006 |
Travoprost 0.004%/timolol 0.5% fixed combination.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Cloprostenol; Drug Combinations; Glaucoma, Open-Angle; Humans; Ocular Hypertension; Timolol; Travoprost | 2007 |
Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Circadian Rhythm; Cloprostenol; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Exfoliation Syndrome; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Single-Blind Method; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Travoprost; Treatment Outcome | 2008 |
Travoprost/timolol fixed combination.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Cloprostenol; Drug Combinations; Glaucoma, Open-Angle; Humans; Ocular Hypertension; Patient Compliance; Timolol; Travoprost | 2008 |
[Cost-efficacy analysis of fixed combinations of prostaglandin/prostamide for treating glaucoma].
Topics: Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Cost-Benefit Analysis; Drug Combinations; Glaucoma; Humans; Latanoprost; Middle Aged; Prostaglandins F, Synthetic; Timolol; Travoprost | 2008 |
[Fixed combinations of glaucoma medications].
Topics: Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate; Cloprostenol; Drug Combinations; Drug Therapy, Combination; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Travoprost; Treatment Outcome | 2008 |
[Development of conjunctival hyperemia with the use of a fixed combination of latanoprost/timolol: systematic review and meta-analysis of clinical trials].
Topics: Aged; Brimonidine Tartrate; Clinical Trials as Topic; Cloprostenol; Conjunctival Diseases; Cross-Over Studies; Drug Combinations; Drug Therapy, Combination; Glaucoma; Humans; Hyperemia; Latanoprost; Middle Aged; Ocular Hypertension; Odds Ratio; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiazines; Timolol; Travoprost | 2009 |
Meta-analysis of medical intervention for normal tension glaucoma.
Topics: Aged; Amides; Antihypertensive Agents; Betaxolol; Bimatoprost; Brimonidine Tartrate; Cloprostenol; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Quinoxalines; Randomized Controlled Trials as Topic; Sulfonamides; Thiazines; Thiophenes; Timolol; Tonometry, Ocular; Travoprost | 2009 |
[Bimatoprost therapy in glaucoma].
Topics: Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Drug Therapy, Combination; Evidence-Based Medicine; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Timolol; Travoprost; Treatment Outcome | 2009 |
Travoprost/timolol fixed combination in the management of open-angle glaucoma: a clinical review.
Topics: Animals; Antihypertensive Agents; Cloprostenol; Drug Combinations; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Timolol; Travoprost | 2011 |
Overview of the [corrected] travoprost /timolol BAK-free fixed combination.
Topics: Animals; Antihypertensive Agents; Benzalkonium Compounds; Cloprostenol; Drug Combinations; Glaucoma; Humans; Preservatives, Pharmaceutical; Timolol; Travoprost | 2012 |
[The latest developments in glaucoma therapy using fixed combination products].
Topics: Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate, Timolol Maleate Drug Combination; Carbonic Anhydrase Inhibitors; Cloprostenol; Drug Combinations; Drug Therapy, Combination; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiazines; Thiophenes; Timolol; Travoprost; Treatment Outcome | 2011 |
[Fixed combination of topical prostaglandin analogue in glaucoma treatment].
Topics: Amides; Antihypertensive Agents; Bimatoprost; Carbonic Anhydrase Inhibitors; Cloprostenol; Drug Combinations; Drug Therapy, Combination; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Optic Nerve; Prostaglandins F, Synthetic; Prostaglandins, Synthetic; Sulfonamides; Thiazines; Timolol; Travoprost; Treatment Outcome; Visual Fields | 2011 |
Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Prostaglandins F; Prostaglandins F, Synthetic; Prostaglandins, Synthetic; Randomized Controlled Trials as Topic; Timolol; Travoprost | 2014 |
Efficacy and tolerability of prostaglandin-timolol fixed combinations: an updated systematic review and meta-analysis.
Topics: Antihypertensive Agents; Bimatoprost; Drug Combinations; Glaucoma; Humans; Hyperemia; Intraocular Pressure; Latanoprost; Prostaglandins F, Synthetic; Timolol; Travoprost | 2015 |
The efficacy of the fixed combination of latanoprost and timolol versus other fixed combinations for primary open-angle glaucoma and ocular hypertension: A systematic review and meta-analysis.
Topics: Antihypertensive Agents; Bimatoprost; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Ocular Hypertension; Sulfonamides; Thiophenes; Timolol; Travoprost; Treatment Outcome | 2020 |
Short-term efficacy of latanoprostene bunod for the treatment of open-angle glaucoma and ocular hypertension: a systematic literature review and a network meta-analysis.
Topics: Amides; Antihypertensive Agents; Bayes Theorem; Betaxolol; Bimatoprost; Brimonidine Tartrate; Carteolol; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Network Meta-Analysis; Ocular Hypertension; Prostaglandins A; Prostaglandins F, Synthetic; Timolol; Travoprost | 2022 |
49 trial(s) available for timolol and travoprost
| Article | Year |
|---|---|
Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cloprostenol; Double-Blind Method; Eye Color; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iris; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Pigmentation Disorders; Prodrugs; Prostaglandins F, Synthetic; Safety; Timolol; Travoprost; Treatment Outcome | 2001 |
Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension.
Topics: Administration, Topical; Aged; Antihypertensive Agents; Cloprostenol; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Safety; Timolol; Travoprost; Treatment Outcome | 2001 |
Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Antihypertensive Agents; Chemotherapy, Adjuvant; Cloprostenol; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Safety; Timolol; Travoprost | 2001 |
Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Cloprostenol; Double-Blind Method; Drug Evaluation; Female; Glaucoma, Open-Angle; Heart Rate; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Safety; Timolol; Travoprost; Treatment Outcome | 2002 |
Projected impact of travoprost versus both timolol and latanoprost on visual field deficit progression and costs among black glaucoma subjects.
Topics: Aged; Antihypertensive Agents; Black People; Cloprostenol; Disease Progression; Double-Blind Method; Drug Costs; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Timolol; Travoprost; United States; Vision Disorders; Visual Fields | 2002 |
[Structural and immunohistochemical changes of conjunctiva induced by topical glaucoma medication].
Topics: Administration, Topical; Adrenergic beta-Antagonists; Antihypertensive Agents; Benzalkonium Compounds; Betaxolol; Carbonic Anhydrase Inhibitors; Cloprostenol; Conjunctiva; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Immunohistochemistry; Ophthalmic Solutions; Preservatives, Pharmaceutical; Prospective Studies; Sulfonamides; Thiophenes; Timolol; Travoprost | 2004 |
Concomitant administration of travoprost and brinzolamide versus fixed latanoprost/timolol combined therapy: three-month comparison of efficacy and safety.
Topics: Cloprostenol; Drug Combinations; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Sulfonamides; Thiazines; Timolol; Travoprost | 2004 |
The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Cloprostenol; Double-Blind Method; Drug Combinations; Female; Glaucoma, Open-Angle; Heart Rate; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Safety; Timolol; Travoprost; Treatment Outcome | 2005 |
Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension.
Topics: Antihypertensive Agents; Cloprostenol; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Safety; Timolol; Travoprost; Treatment Outcome | 2005 |
A three-month, multicenter, double-masked study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to travoprost 0.004% ophthalmic solution and timolol 0.5% dosed concomitantly in subjects with open angle glaucoma or
Topics: Aged; Antihypertensive Agents; Cloprostenol; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Timolol; Travoprost; Treatment Outcome | 2005 |
Comparative analysis of the efficacy and safety of latanoprost, travoprost and the fixed combination timolol-dorzolamide; a prospective, randomized, masked, cross-over design study.
Topics: Aged; Antihypertensive Agents; Cloprostenol; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Latanoprost; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol; Travoprost; Treatment Outcome | 2005 |
A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
Topics: Aged; Antihypertensive Agents; Cloprostenol; Double-Blind Method; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Travoprost; Treatment Outcome | 2006 |
A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Aged; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Cloprostenol; Double-Blind Method; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Quinoxalines; Sulfonamides; Thiazines; Timolol; Travoprost | 2006 |
[Combined therapy in glaucoma treatment: travoprost 0.004% and brinzolamid].
Topics: Adrenergic beta-Antagonists; Aged; Carbonic Anhydrase Inhibitors; Cloprostenol; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Sulfonamides; Thiazines; Timolol; Travoprost | 2006 |
Travoprost versus latanoprost combinations in glaucoma: economic evaluation based on visual field deficit progression.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Cloprostenol; Double-Blind Method; Drug Costs; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Timolol; Travoprost; Visual Fields | 2006 |
Comparison of the efficacy and safety of travoprost with a fixed-combination of dorzolamide and timolol in patients with open-angle glaucoma or ocular hypertension.
Topics: Cloprostenol; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Single-Blind Method; Sulfonamides; Thiophenes; Timolol; Travoprost | 2006 |
The effect of ocular hypotensive agents on macula.
Topics: Administration, Topical; Adult; Aged; Amides; Bimatoprost; Cloprostenol; Drug Administration Schedule; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Latanoprost; Lipids; Macula Lutea; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Travoprost; Visual Acuity; Visual Field Tests | 2007 |
Intraocular pressure reduction with travoprost/timolol fixed combination, with and without adjunctive brinzolamide, in glaucoma.
Topics: Aged; Cloprostenol; Drug Combinations; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Sulfonamides; Thiazines; Timolol; Travoprost | 2008 |
Changes in visual function after intraocular pressure reduction using antiglaucoma medications.
Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Cloprostenol; Contrast Sensitivity; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Prospective Studies; Quinoxalines; Timolol; Travoprost; Visual Acuity; Visual Fields; Visual Perception | 2009 |
[Comparison of intraocular pressure lowering efficacy of bimatoprost / timolol fixed combination and other glaucoma medications in the treatment of glaucoma].
Topics: Adult; Aged; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Drug Combinations; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Middle Aged; Ocular Hypotension; Prostaglandins F, Synthetic; Timolol; Travoprost | 2008 |
Intraocular pressure control with latanoprost/timolol and travoprost/timolol fixed combinations : a retrospective, multicentre, cross-sectional study.
Topics: Adult; Aged; Cloprostenol; Cross-Sectional Studies; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Retrospective Studies; Timolol; Travoprost | 2008 |
Twenty-four-hour intraocular pressure control with the travoprost/timolol maleate fixed combination compared with travoprost when both are dosed in the evening in primary open-angle glaucoma.
Topics: Adult; Aged; Antihypertensive Agents; Circadian Rhythm; Cloprostenol; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Timolol; Travoprost; Treatment Outcome | 2009 |
Intraocular pressure control over 24 hours using travoprost and timolol fixed combination administered in the morning or evening in primary open-angle and exfoliative glaucoma.
Topics: Adult; Antihypertensive Agents; Circadian Rhythm; Cloprostenol; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Exfoliation Syndrome; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Prospective Studies; Timolol; Tonometry, Ocular; Travoprost; Visual Acuity | 2009 |
Switching from concomitant latanoprost 0.005% and timolol 0.5% to a fixed combination of travoprost 0.004%/timolol 0.5% in patients with primary open-angle glaucoma and ocular hypertension: a 6-month, multicenter, cohort study.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cloprostenol; Cohort Studies; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Preservatives, Pharmaceutical; Prostaglandins F, Synthetic; Tears; Time Factors; Timolol; Travoprost | 2009 |
The effect of travoprost 0.004% as an adjuvant to timolol 0.5% therapy.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Antihypertensive Agents; Cloprostenol; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Timolol; Travoprost | 2009 |
Monitoring adherence rates in glaucoma patients using the Travatan Dosing Aid. A 6-month study comparing patients on travoprost 0.004% and patients on travoprost 0.004%/timolol 0.5% fixed combination.
Topics: Aged; Antihypertensive Agents; Cloprostenol; Drug Combinations; Drug Monitoring; Female; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Ophthalmic Solutions; Patient Compliance; Prospective Studies; Timolol; Travoprost; Treatment Outcome | 2010 |
24-h Intraocular pressure control with evening-dosed travoprost/timolol, compared with latanoprost/timolol, fixed combinations in exfoliative glaucoma.
Topics: Aged; Antihypertensive Agents; Cloprostenol; Cross-Over Studies; Drug Administration Schedule; Drug Therapy, Combination; Exfoliation Syndrome; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prospective Studies; Prostaglandins F, Synthetic; Single-Blind Method; Time Factors; Timolol; Travoprost | 2010 |
Comparison of Travoprost and Bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combination.
Topics: Aged; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Cross-Over Studies; Double-Blind Method; Drug Combinations; Glaucoma, Open-Angle; Gonioscopy; Humans; Intraocular Pressure; Latanoprost; Prospective Studies; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Travoprost; Visual Acuity | 2010 |
Intraocular pressure-lowering efficacy of brinzolamide when added to travoprost/timolol fixed combination as adjunctive therapy.
Topics: Aged; Antihypertensive Agents; Cloprostenol; Double-Blind Method; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Sulfonamides; Thiazines; Timolol; Tonometry, Ocular; Travoprost; Treatment Outcome; Visual Acuity | 2012 |
Observational study of patients switched to the fixed travoprost 0.004%/timolol 0.5% combination in Croatia.
Topics: Antihypertensive Agents; Cloprostenol; Croatia; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Ocular Hypertension; Ophthalmic Solutions; Patient Satisfaction; Prospective Studies; Timolol; Travoprost; Treatment Outcome | 2010 |
Timolol versus brinzolamide added to travoprost in glaucoma or ocular hypertension.
Topics: Aged; Antihypertensive Agents; Cloprostenol; Double-Blind Method; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Sulfonamides; Thiazines; Timolol; Tonometry, Ocular; Travoprost; Treatment Outcome | 2011 |
Travoprost 0.004%/timolol 0.5%-fixed combination with and without benzalkonium chloride: a prospective, randomized, doubled-masked comparison of safety and efficacy.
Topics: Aged; Antihypertensive Agents; Benzalkonium Compounds; Cloprostenol; Double-Blind Method; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Japan; Logistic Models; Male; Middle Aged; Ocular Hypertension; Polymers; Prospective Studies; Timolol; Travoprost; United States | 2011 |
24-Hour intraocular pressure control between travoprost/timolol fixed combination, latanoprost/ timolol fixed combination and standard timolol in primary open angle glaucoma and ocular hypertension.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cloprostenol; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Time Factors; Timolol; Travoprost; Treatment Outcome; Young Adult | 2011 |
Travoprost 0.004%/timolol 0.5% fixed combination in patients transitioning from fixed or unfixed bimatoprost 0.03%/timolol 0.5%.
Topics: Adult; Aged; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Drug Combinations; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Timolol; Travoprost | 2011 |
[The influence of the Travalert(®) dosing aid on medical treatment compliance and the quality of life of glaucoma patients].
Topics: Administration, Ophthalmic; Aged; Anxiety; Cloprostenol; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Glaucoma; Humans; Instillation, Drug; Male; Medication Adherence; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Quality of Life; Reminder Systems; Surveys and Questionnaires; Timolol; Travoprost | 2011 |
Adherence improvement in Dutch glaucoma patients: a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Cloprostenol; Drug Combinations; Drug Monitoring; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Medication Adherence; Middle Aged; Netherlands; Ocular Hypertension; Ophthalmic Solutions; Patient Compliance; Patient Education as Topic; Surveys and Questionnaires; Timolol; Tonometry, Ocular; Travoprost | 2013 |
Effect of prophylactic intraocular pressure-lowering medication on pain during cataract surgery.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate; Cataract; Cloprostenol; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Pain; Phacoemulsification; Postoperative Period; Prospective Studies; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Travoprost | 2013 |
Comparison of 24-hour intraocular pressure reduction obtained with brinzolamide/timolol or brimonidine/timolol fixed-combination adjunctive to travoprost therapy.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Cloprostenol; Cross-Over Studies; Drug Combinations; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Prospective Studies; Quinoxalines; Sulfonamides; Thiophenes; Time Factors; Timolol; Travoprost | 2013 |
Hypotensive effect of latanoprost/timolol versus travoprost/timolol fixed combinations in NTG patients: a randomized, multicenter, crossover clinical trial.
Topics: Aged; Antihypertensive Agents; Cloprostenol; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Intraocular Pressure; Latanoprost; Low Tension Glaucoma; Male; Middle Aged; Prospective Studies; Prostaglandins F, Synthetic; Single-Blind Method; Timolol; Travoprost | 2013 |
A randomized, prospective study of bimatoprost 0.01% or travoprost/timolol in patients previously treated with latanoprost and timolol to reduce intraocular pressure.
Topics: Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Cross-Over Studies; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Hyperemia; Intraocular Pressure; Latanoprost; Male; Middle Aged; Patient Preference; Prospective Studies; Prostaglandins F, Synthetic; Single-Blind Method; Timolol; Travoprost; Treatment Outcome | 2013 |
Ocular surface evaluation in patients treated with a fixed combination of prostaglandin analogues with 0.5% timolol maleate topical monotherapy: a randomized clinical trial.
Topics: Aged; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Drug Combinations; Eye; Female; Glaucoma, Open-Angle; HLA-DR Antigens; Humans; Immunohistochemistry; Interleukin-6; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Prostaglandins, Synthetic; Single-Blind Method; Timolol; Travoprost; Treatment Outcome | 2013 |
[Clinical efficacy of travoprost-timolol fixed combination on ocular hypotensive agents and ocular surface agents in Japanese glaucoma patients].
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Asian People; Cloprostenol; Cornea; Dinoprost; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ophthalmic Solutions; Patient Satisfaction; Surveys and Questionnaires; Timolol; Travoprost; Treatment Outcome | 2013 |
24-hour efficacy of travoprost/timolol BAK-free versus latanoprost/timolol fixed combinations in patients insufficiently controlled with latanoprost.
Topics: Antihypertensive Agents; Cross-Over Studies; Drug Combinations; Drug Monitoring; Drug Synergism; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Neuroprotective Agents; Prospective Studies; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Travoprost; Treatment Outcome | 2014 |
Comparing the efficacy of latanoprost (0.005%), bimatoprost (0.03%), travoprost (0.004%), and timolol (0.5%) in the treatment of primary open angle glaucoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Bimatoprost; Blood Pressure; Female; Glaucoma, Open-Angle; Heart Rate; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Travoprost; Treatment Outcome; Visual Acuity; Visual Field Tests; Visual Fields | 2014 |
Adherence to Fixed-Combination Versus Unfixed Travoprost 0.004%/Timolol 0.5% for Glaucoma or Ocular Hypertension: A Randomized Trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Instillation, Drug; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Patient Compliance; Single-Blind Method; Time Factors; Timolol; Tonometry, Ocular; Travoprost; Treatment Outcome | 2017 |
The efficacy and safety of bimatoprost/timolol maleate, latanoprost/timolol maleate, and travoprost/timolol maleate fixed combinations on 24-h IOP.
Topics: Aged; Aged, 80 and over; Bimatoprost; Circadian Rhythm; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma, Open-Angle; Gonioscopy; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Monitoring, Physiologic; Prospective Studies; Prostaglandins F, Synthetic; Single-Blind Method; Timolol; Tonometry, Ocular; Travoprost; Treatment Outcome | 2018 |
A 3-month safety and efficacy study of travoprost 0.004% ophthalmic solution compared with timolol in pediatric patients with glaucoma or ocular hypertension.
Topics: Adolescent; Antihypertensive Agents; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Equivalence Trials as Topic; Female; Glaucoma; Humans; Infant; Intraocular Pressure; Male; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Timolol; Tonometry, Ocular; Travoprost | 2017 |
Effect of Topical Hypotensive Medications for Preventing Intraocular Pressure Increase after Cataract Surgery in Eyes with Glaucoma.
Topics: Aged; Antihypertensive Agents; Carbonic Anhydrase Inhibitors; Cataract; Cataract Extraction; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Ocular Hypertension; Ophthalmic Solutions; Postoperative Complications; Prospective Studies; Sulfonamides; Thiazines; Timolol; Tonometry, Ocular; Travoprost; Treatment Outcome | 2019 |
Efficacy And Safety Of Travoprost Versus Timolol To Treat Early-Onset Ocular Hypertension Secondary To Vitrectomy: A Randomized Trial.
Topics: Female; Humans; Inflammation; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Risk Factors; Single-Blind Method; Timolol; Travoprost; Vitrectomy | 2019 |
35 other study(ies) available for timolol and travoprost
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Cloprostenol; Drug Evaluation; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Prostaglandins F, Synthetic; Safety; Timolol; Travoprost | 2002 |
Comparison of tropical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension. J. Glaucoma 2001;10:414-22.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Cloprostenol; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Ocular Hypertension; Ophthalmic Solutions; Safety; Timolol; Travoprost | 2002 |
Identification and characterization of the ocular hypotensive efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist, and AL-6598, a DP prostaglandin receptor agonist.
Topics: Animals; Antihypertensive Agents; Aqueous Humor; Cats; Cloprostenol; Dinoprost; Dose-Response Relationship, Drug; Female; Glaucoma, Open-Angle; Guinea Pigs; Humans; Intraocular Pressure; Macaca fascicularis; Male; Ocular Hypertension; Rabbits; Randomized Controlled Trials as Topic; Receptors, Immunologic; Receptors, Prostaglandin; Safety; Structure-Activity Relationship; Timolol; Travoprost | 2002 |
Modern alchemy: fixed combinations of glaucoma drugs.
Topics: Antihypertensive Agents; Cloprostenol; Drug Combinations; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Ocular Hypertension; Ophthalmic Solutions; Safety; Timolol; Travoprost; Treatment Outcome | 2005 |
Does timolol LA enhance the disrupting effect of travoprost on the blood-aqueous barrier?
Topics: Adult; Antihypertensive Agents; Blood-Aqueous Barrier; Cloprostenol; Drug Synergism; Drug Therapy, Combination; Gonioscopy; Humans; Intraocular Pressure; Male; Ocular Hypertension; Timolol; Travoprost; Uveitis, Anterior | 2006 |
Costs and effectiveness of travoprost versus a dorzolamide + timolol fixed combination in first-line treatment of glaucoma: analysis conducted on the United Kingdom General Practitioner Research Database.
Topics: Aged; Antihypertensive Agents; Cloprostenol; Cost-Benefit Analysis; Databases, Factual; Drug Combinations; Drug Costs; Female; Glaucoma; Humans; Male; Physicians, Family; Sulfonamides; Thiophenes; Timolol; Travoprost; United Kingdom | 2007 |
A cost-effectiveness analysis of fixed-combination therapies in patients with open-angle glaucoma: a European perspective.
Topics: Adrenergic beta-Antagonists; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Cost-Benefit Analysis; Decision Support Techniques; Drug Therapy, Combination; Europe; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Models, Economic; Prostaglandins F, Synthetic; Prostaglandins, Synthetic; Timolol; Travoprost | 2008 |
Observational study results in glaucoma patients undergoing a regimen replacement to fixed combination travoprost 0.004%/timolol 0.5% in Germany.
Topics: Aged; Chemistry, Pharmaceutical; Cloprostenol; Drug Combinations; Female; Germany; Glaucoma; Humans; Male; Middle Aged; Timolol; Travoprost | 2008 |
A case of melancholic depression induced by beta-blocker antiglaucoma agents.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Cloprostenol; Depressive Disorder; Drug Combinations; Glaucoma; Humans; Male; Ophthalmic Solutions; Timolol; Travoprost | 2008 |
Cost effectiveness of travoprost versus a fixed combination of latanoprost/timolol in patients with ocular hypertension or glaucoma: analysis based on the UK general practitioner research database.
Topics: Aged; Antihypertensive Agents; Cloprostenol; Cost-Benefit Analysis; Databases, Factual; Drug Combinations; Female; Glaucoma; Humans; Latanoprost; Male; Ocular Hypertension; Ophthalmic Solutions; Physicians, Family; Prostaglandins F, Synthetic; Timolol; Travoprost; United Kingdom | 2009 |
Corneal thickness and glaucoma medications.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Circadian Rhythm; Cloprostenol; Cornea; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Exfoliation Syndrome; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Single-Blind Method; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Travoprost; Treatment Outcome | 2009 |
Relative efficacy of prostaglandins.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Circadian Rhythm; Cloprostenol; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Exfoliation Syndrome; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Single-Blind Method; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Travoprost; Treatment Outcome | 2009 |
Efficiency of travoprost versus fixed-combination latanoprost/timolol.
Topics: Antihypertensive Agents; Cloprostenol; Drug Combinations; Glaucoma; Humans; Latanoprost; Ocular Hypotension; Prostaglandins F, Synthetic; Timolol; Travoprost; Treatment Failure | 2009 |
Comparison of evening and morning dosing of travoprost 0.004%/timolol 0.5% fixed combination in 6 month period.
Topics: Cloprostenol; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Prospective Studies; Timolol; Travoprost | 2010 |
Hyperemia reduction after administration of a fixed combination of bimatoprost and timolol maleate to patients on prostaglandin or prostamide monotherapy.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Drug Combinations; Follow-Up Studies; Glaucoma; Humans; Hyperemia; Intraocular Pressure; Latanoprost; Longitudinal Studies; Prostaglandins F, Synthetic; Time Factors; Timolol; Travoprost | 2010 |
In vitro comparative toxicology of polyquad-preserved and benzalkonium chloride-preserved travoprost/timolol fixed combination and latanoprost/timolol fixed combination.
Topics: Apoptosis; Benzalkonium Compounds; Cell Line; Cell Survival; Chemistry, Pharmaceutical; Clone Cells; Cloprostenol; Conjunctiva; Drug Combinations; Epithelial Cells; Humans; Latanoprost; Ocular Hypertension; Ophthalmic Solutions; Oxidative Stress; Polymers; Preservatives, Pharmaceutical; Prostaglandins F, Synthetic; Superoxides; Sympatholytics; Timolol; Travoprost | 2011 |
Polyquad-preserved travoprost/timolol, benzalkonium chloride (BAK)-preserved travoprost/timolol, and latanoprost/timolol in fixed combinations: a rabbit ocular surface study.
Topics: Animals; Anti-Bacterial Agents; Antihypertensive Agents; Benzalkonium Compounds; Cell Survival; Cloprostenol; Conjunctiva; Disease Models, Animal; Drug Combinations; Epithelium, Corneal; Latanoprost; Male; Ocular Hypertension; Ophthalmic Solutions; Polymers; Preservatives, Pharmaceutical; Prostaglandins F, Synthetic; Rabbits; Timolol; Travoprost; Treatment Outcome | 2011 |
[In vitro evaluation for corneal damages by anti-glaucoma combination eye drops using human corneal epithelial cell (HCE-T)].
Topics: Antihypertensive Agents; Cells, Cultured; Cloprostenol; Cornea; Drug Combinations; Epithelial Cells; Glaucoma; Humans; In Vitro Techniques; Latanoprost; Mannitol; Ophthalmic Solutions; Polymers; Preservatives, Pharmaceutical; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol; Travoprost | 2011 |
Characterization of intraocular pressure responses of the Tibetan monkey (Macaca thibetana).
Topics: Animals; Antihypertensive Agents; Circadian Rhythm; Cloprostenol; Eye; Glaucoma; Intraocular Pressure; Macaca; Male; Models, Animal; Naphazoline; Pyrrolidines; Timolol; Tonometry, Ocular; Travoprost | 2011 |
Asymmetry of 24-hour intraocular pressure reduction by topical ocular hypotensive medications in fellow eyes.
Topics: Administration, Topical; Adult; Aged; Antihypertensive Agents; Brimonidine Tartrate; Circadian Rhythm; Cloprostenol; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Posture; Prostaglandins F, Synthetic; Quinoxalines; Retrospective Studies; Sulfonamides; Thiazines; Timolol; Tonometry, Ocular; Travoprost | 2011 |
Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells.
Topics: Antihypertensive Agents; Apoptosis; Benzalkonium Compounds; Cell Survival; Cells, Cultured; Cloprostenol; Drug Combinations; Fluoresceins; Glaucoma; Humans; Latanoprost; Matrix Metalloproteinase 9; Polymers; Preservatives, Pharmaceutical; Prostaglandins F, Synthetic; Timolol; Trabecular Meshwork; Travoprost | 2011 |
Long-term outcomes of prostaglandin analog versus timolol maleate in ocular hypertensive or primary open-angle glaucoma patients in Europe.
Topics: Aged; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Disease Progression; Drug Costs; Europe; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Retrospective Studies; Time Factors; Timolol; Travoprost; Treatment Outcome | 2011 |
Safety and efficacy of monotherapy change to fixed combination (travoprost 0.004%/timolol 0.5%) in 6 months follow up period.
Topics: Antihypertensive Agents; Cloprostenol; Drug Combinations; Drug Substitution; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Ocular Hypertension; Timolol; Travoprost | 2010 |
Effects of antiglaucoma drugs on the ocular surface in rabbits: a fixed-combination drug versus two concomitant drugs.
Topics: Animals; Antihypertensive Agents; Cloprostenol; Conjunctiva; Cornea; Drug Combinations; Drug Therapy, Combination; Epithelial Cells; Male; Rabbits; Timolol; Travoprost | 2011 |
The effect of additional topical cyclosporine or vitamin A on the ocular surface during antiglaucoma medication administration.
Topics: Administration, Topical; Animals; Antihypertensive Agents; Cloprostenol; Conjunctiva; Conjunctival Diseases; Cyclosporine; Drug Combinations; Drug Therapy, Combination; Goblet Cells; Immunosuppressive Agents; Male; Ophthalmic Solutions; Rabbits; Timolol; Travoprost; Vitamin A; Vitamins | 2012 |
Efficacy and safety of switching to travoprost/timolol fixed-combination therapy from latanoprost monotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Cloprostenol; Drug Combinations; Drug Substitution; Female; Glaucoma, Open-Angle; Heart Rate; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Surveys and Questionnaires; Timolol; Tonometry, Ocular; Travoprost; Treatment Outcome; Young Adult | 2012 |
Surface chemistry study of the interactions of pharmaceutical ingredients with human meibum films.
Topics: Adult; Animals; Antihypertensive Agents; Benzalkonium Compounds; Cloprostenol; Cornea; Drug Combinations; Female; Humans; Male; Meibomian Glands; Membrane Lipids; Ophthalmic Solutions; Preservatives, Pharmaceutical; Rabbits; Surface Properties; Surface Tension; Tears; Timolol; Travoprost | 2012 |
Hemorrhagic choroidal detachment after use of anti-glaucomatous eye drops: case report.
Topics: Aged, 80 and over; Antihypertensive Agents; Choroid; Choroid Hemorrhage; Cloprostenol; Glaucoma; Humans; Intraocular Pressure; Male; Ophthalmic Solutions; Timolol; Travoprost; Ultrasonography | 2013 |
Evaluation of Efficacy and Safety of Latanoprost/Timolol versus Travoprost/Timolol Fixed Combinations for Ocular Hypertension Associated with Uveitis.
Topics: Antihypertensive Agents; Drug Combinations; Female; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Retrospective Studies; Timolol; Tonometry, Ocular; Travoprost; Treatment Outcome; Uveitis | 2017 |
Meibomian Gland Features and Conjunctival Goblet Cell Density in Glaucomatous Patients Controlled With Prostaglandin/Timolol Fixed Combinations: A Case Control, Cross-sectional Study.
Topics: Aged; Antihypertensive Agents; Bimatoprost; Case-Control Studies; Cell Count; Conjunctiva; Cross-Sectional Studies; Drug Combinations; Female; Glaucoma; Goblet Cells; Humans; Intraocular Pressure; Latanoprost; Male; Meibomian Glands; Microscopy, Confocal; Middle Aged; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Travoprost | 2018 |
Association of Postoperative Topical Prostaglandin Analog or Beta-Blocker Use and Incidence of Pseudophakic Cystoid Macular Edema.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Bimatoprost; Case-Control Studies; Cataract; Cataract Extraction; Combined Modality Therapy; Female; Humans; Incidence; Intraocular Pressure; Latanoprost; Macular Edema; Male; Middle Aged; Postoperative Complications; Postoperative Period; Prostaglandins, Synthetic; Pseudophakia; Timolol; Travoprost | 2018 |
Patient Preference-Based Comparative Effectiveness and Cost-Utility Analysis of the Prostamides for Open-Angle Glaucoma.
Topics: Bimatoprost; Cost-Benefit Analysis; Glaucoma, Open-Angle; Health Care Costs; Humans; Intraocular Pressure; Latanoprost; Patient Preference; Prostaglandins F; Timolol; Travoprost; Visual Acuity | 2019 |
Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment.
Topics: Adult; Antihypertensive Agents; Bimatoprost; Drug Combinations; Glaucoma; Glaucoma, Open-Angle; Humans; Hyperemia; Intraocular Pressure; Latanoprost; Ocular Hypertension; Prospective Studies; Prostaglandins A; Prostaglandins F; Timolol; Travoprost | 2022 |
Primary Open-Angle Glaucoma Progression in Glaucoma Patients with Unchanged Topical Treatment over 3 Years - Retrospective Observational Cohort Analysis.
Topics: Administration, Topical; Antihypertensive Agents; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ophthalmic Solutions; Retinal Ganglion Cells; Retrospective Studies; Timolol; Travoprost | 2023 |